Overview
Jeffrey De Fauw practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Age-Related Macular Degeneration (ARMD) and Late-Onset Retinal Degeneration.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jeffrey De Fauw
Is Jeffrey De Fauw a top-rated expert for Age-Related Macular Degeneration (ARMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Jeffrey De Fauw is classified as an Experienced expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jeffrey De Fauw participate in research or clinical trials?
Yes. Jeffrey De Fauw has published 8 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Jeffrey De Fauw's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. De Fauw isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationMr. De Fauw isExperienced. Learn about Late-Onset Retinal Degeneration.